Publications & Talks
Our Research / Publications & Talks
The Limitations of Animal Models of Neurodegenerative Disease.
Benatar M (invited speaker). The Limitations of Animal Models of Neurodegenerative Disease. TREAT-NMD/NIH International Conference: Bottlenecks in Translational Medicine in Inherited Neuromuscular Diseases. Brussels, Belgium, November 2009.
Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS.
Benatar M (invited speaker). Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS. ALS Association Drug Discovery Symposium. Seattle, WA, May 2009.
Phase II/III Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS.
Benatar M (invited speaker). Phase II/III Randomized Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS. Packard Center 9th Annual Meeting. Baltimore, MD, April 2009.
Panel discussant on the topic of Animal Models for Neurological Disease: Success or Lack of Success for Translation.
Benatar M (invited speaker). Panel discussant on the topic of Animal Models for Neurological Disease: Success or Lack of Success for Translation. NINDS Training and Implementation Retreat. Airlie House, Warrenton, VA, March 2009.
Multisystem Proteinopathy: Implications for ALS/MND.
Benatar M (invited speaker). Multisystem Proteinopathy: Implications for ALS/MND. Visiting Professor and Guest Lecturer, South African Neurological Association Meeting. Johannesburg, South Africa, March 2009.
Lessons for Huntington’s Disease from Amyotrophic Lateral Sclerosis.
Benatar M (invited speaker). Lessons for Huntington’s Disease from Amyotrophic Lateral Sclerosis. World Huntington’s Conference. Vancouver, Canada, September 2009.
Piecing Together the Puzzle of ALS: An Emerging Picture.
Benatar M (invited speaker). Piecing Together the Puzzle of ALS: An Emerging Picture. Visiting Professor and Guest Lecturer, South African Neurological Association Meeting. Johannesburg, South Africa, March 2009.
Predictive, Preventive and Therapeutic Studies in Familial ALS.
Benatar M (invited speaker). Predictive, Preventive and Therapeutic Studies in Familial ALS. ALS Association Annual Leadership Forum. Orange County, CA, January 2008.
Strategies for pre-symptomatic biomarker identification in familial ALS.
Benatar M (invited speaker). Strategies for pre-symptomatic biomarker identification in familial ALS. Cold Spring Harbor Symposium on Drug Discovery, Biomarkers, and Clinical Trials for ALS. Banbury Center, Cold Spring Harbor, NY, September 2007.